Rare diseases
Investigational molecules
Locations
Back to Germany2 clinical trials in Boehlen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
GermanyEfficacy and Safety of Amara‑Tropfen Dilution vs Placebo in Patients with Irritable Bowel Syndrome
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Irritable Bowel Syndrome (IBS), specifically targeting the diarrhea-predominant form. The research evaluates an innovative bacterial treatment approach using E. coli DSM 17252 to improve digestive health outcomes.
This trial aims to advance treatment options for patients dealing with chronic digestive symptoms.
Groundbreaking research into IgG4-Related Disease, evaluating the effectiveness of obexelimab administered subcutaneously. The study focuses on preventing disease flares following glucocorticoid therapy.
This research represents a significant step forward in developing targeted treatments for rare immunological disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
